Welcome to our dedicated page for NITCHES news (Ticker: NICH), a resource for investors and traders seeking the latest updates and insights on NITCHES stock.
Nitches Inc. reports on its human performance and wellness platform, with recurring updates centered on InTheZone Labs, its wholly owned subsidiary. Company news focuses on nootropic and nutraceutical products for brain health, recovery, focus, energy and wellness, along with domestic formulation, quality controls and compliant marketing.
Updates also cover affiliate and distributor expansion through social-commerce and online channels, GovX-supported programs for service communities, subsidiary commercialization plans, and the company's audit and reporting-status initiatives.
Nitches Inc. (OTC:NICH) announces significant expansion of InTheZone Labs through multiple strategic initiatives. The company has onboarded over 25 new affiliates through ShareASale and Awin networks, and partnered with Honey by PayPal, a platform with 29 million members globally. Additionally, InTheZone Labs received approval to list products across all Amazon stores globally, with integration currently in progress.
The company operates in the nutraceutical market, which is projected to reach $620.3 billion by 2030, while the nootropics sector expects a 14.6% CAGR from 2023 to 2030. Phase One Testing results are forthcoming, featuring feedback from initial product testers.
Nitches Inc. (OTC PINK:NICH) announces a new 2025 ad campaign for its subsidiary, InTheZone Labs, featuring WWE Hall of Famer Kurt Angle. The campaign promotes their product 'Focused Extreme' and introduces a new YouTube channel for educational content about nutraceuticals.
The company is launching an expanded affiliate marketing program through ShareASale and Awin networks, offering up to 40% commission rates for accredited affiliates. The initiative includes access to marketing materials and promotional content.
InTheZone Labs is finalizing Phase 1 testing results of its products and expanding its Advisory Board. The company is also preparing for Amazon placement updates and website developments, positioning itself in the nutraceutical and nootropic markets, which are projected to reach $400 billion globally by 2027.
InTheZone Labs has announced an enhanced affiliate marketing program offering a 40% lifetime commission rate for qualified digital influencers, significantly above the industry standard of 10-20%. The program includes ongoing commissions for subscription-based products and comprehensive marketing resources. The company has partnered with Awin and ShareASale affiliate networks, providing access to over 900,000 potential affiliates. This initiative comes amid projected growth in the global nutraceuticals market, expected to reach USD 650.5 billion by 2030 with a 3.9% CAGR.
Nitches Inc. (OTC PINK:NICH) announces strategic developments for its subsidiary InTheZone Labs, including the launch of a new YouTube channel featuring podcast-style product videos and ingredient deep dives. The company is expanding its affiliate marketing initiatives through networks like ShareASale and Awin. InTheZone Labs is preparing to release Phase One Testing results in early December and continues to enhance its website and social media presence. The company offers products like InTheZone Focused Youth for children and InTheZone Focused for adults, targeting the growing nutraceutical market, which is projected to reach USD 976.74 billion by 2032.
Nitches Inc (OTC:NICH) announced key developments for its brand InTheZone Labs. The company is finalizing its Amazon listing process, expected to complete next week. They've joined ShareASale and Awin affiliate networks, offering 20% commissions. Phase One testing of their product Focused Extreme with veterans, former NFL athletes, and medical professionals shows positive results in brain fog reduction and decreased coffee dependence. Testing will conclude by December 7. The company is forming an advisory board and positioning itself in the nutraceuticals market, projected to exceed $650 billion by 2027.
Nitches Inc. (OTC PINK:NICH) announces the launch of its supplement brand, InTheZone Labs, on ShareASale, a major affiliate network with over 240,000 active partners worldwide. The company is currently conducting phase one testing of its supplements with former NFL players, U.S. veterans, medical professionals, and former wrestlers. The products, manufactured in an FDA-compliant facility in America, are receiving positive feedback for cognitive enhancement and stress management. The launch on ShareASale provides affiliates with marketing tools, including banners, text links, and exclusive content, positioning the company to capture a share of the $150 billion global dietary supplements market.
Nitches Inc (OTC PINK:NICH) has initiated Phase One testing of its InTheZone Focused Extreme supplement, led by a U.S. Army veteran First Sergeant. The testing targets feedback from veterans, law enforcement, and firefighters operating in high-stress environments. The supplement, containing ingredients like L-Theanine, Bacopa Monnieri, and Alpha-GPC, aims to enhance clarity and mental resilience. Early feedback from veteran testers has been positive. The company announced that its entire InTheZone product line will be available on Amazon next week, and is pursuing additional affiliate and distribution partnerships.
Nitches (OTC:NICH) announces expansion of InTheZone Labs through new distribution and affiliate opportunities. The company launches an affiliate program offering 20% commission on sales and initiates Phase One Testing with key influencers including medical professionals, former NFL players, and veterans. The company's product line features three bioceutical solutions: InTheZone Focused Extreme, InTheZone Passion, and InTheZone Youth, incorporating ingredients like Alpha-GPC, Lion's Mane Mushroom, and Omega-3 DHA. Early customer feedback reports improvements in focus and mental clarity. Products are currently available for purchase at InTheZoneLabs.com.
Nitches Inc (OTC PINK:NICH) has launched InTheZone Focused Extreme, a new cognitive enhancement supplement under its InTheZone Labs product line. The supplement features key ingredients including Alpha-GPC, Lion's Mane Mushroom, Caffeine Anhydrous, L-Theanine, Bacopa Monnieri (300mg), and Rhodiola Rosea (200mg). The product is manufactured in the USA in FDA-compliant, GMP-certified facilities with ISO 9001 and USP certifications. This launch positions Nitches to capitalize on the growing nutraceutical market, which is projected to exceed $650 billion by 2027.
Nitches, Inc. (OTC PINK:NICH) announces the commencement of Phase One Testing for its InTheZone Labs division's bioceutical products. The company is developing three flagship products: InTheZone Focused Extreme for mental clarity, InTheZone Passion for men's vitality, and InTheZone Youth for cognitive development in children and young adults.
The testing phase will involve three key groups: veterans and their families, medical and chiropractic experts, and former NFL players. This comprehensive approach aims to gather critical insights and refine the products for various demographics. Nitches encourages the public to visit InTheZoneLabs.com to explore and purchase these products.
The company is positioning itself to capitalize on the projected $650 billion nutraceutical and bioceutical market by 2027, offering American-made, science-backed health solutions.